Table 7.
Dose (mg/kg) (AAC, AAL, ACR) |
Allyl Acetate | Allyl Alcohol | Acrolein | |
---|---|---|---|---|
Males | ||||
0 | 1st | ----b | ---- b | --- b |
6, 1.5, 0.75 | 1st | 17.66±1.10** | 13.42±0.63** | 13.82±0.94** |
12, 3, 1.25 | 1st | 51.83±5.28**! | 22.33±0.96** | 18.41±0.80** |
25, 6, 2.5 | 1st | 126.09±8.08** | 54.17±3.23**! | 32.64±1.82** |
50, 12, 5 | 1st | 355.10±15.76**# | 103.25±6.00** | 60.65±3.39** |
100, 25, 10 | 1st | ---- c | 239.20±18.73**# | 63.85±9.45** |
0 | 45th | ---- b | ---- b | ---- b |
6, 1.5, 0.75 | 45th | 57.25±2.74** | 19.59±1.10** | 18.56±1.61** |
12, 3, 1.25 | 45th | 104.43±8.34**! | 37.38±2.68** | 24.07±1.48** |
25, 6, 2.5 | 45th | 260.00±18.61** | 77.74±4.81**! | 42.80±3.02**e |
50, 12, 5 | 45th | 479.70±33.78**# | 140.10±17.59**d | 69.61±3.51** |
100, 25, 10 | 45th | ---- c | 354.40±29.12**# | 44.30±18.50**f |
Females | ||||
0 | 1st | ---- b | ---- b | --- b |
6, 1.5, 0.75 | 1st | 18.63±1.91** | 13.08±0.75** | 12.60±1.22**d |
12, 3, 1.25 | 1st | 63.87±3.77**! | 21.03±0.82** | 17.08±1.39** |
25, 6, 2.5 | 1st | 147.94±17.42** | 44.47±2.39**! | 31.81±2.46** |
50, 12, 5 | 1st | 335.20±33.13**# | 100.22±7.07** | 52.17±3.68** |
100, 25, 10 | 1st | ---- c | 249.13±24.90**# | 73.92±8.15** |
0 | 45th | ---- b | ---- b | ---- b |
6, 1.5, 0.75 | 45th | 33.33±2.56** | 16.91±1.14** | 11.09±0.55** |
12, 3, 1.25 | 45th | 73.60±4.17**! | 36.83±2.14** | 19.34±1.82**d |
25, 6, 2.5 | 45th | 162.92±17.88** | 93.58±7.12**! | 26.56±2.90**e |
50, 12, 5 | 45th | 380.40±36.09**# | 183.40±18.49** | 49.22±7.15**d |
100, 25, 10 | 45th | ---- c | 453.80±26.66**# | 98.20g |
Significantly different (P≤0.01) from vehicle control group by Shirley’s test
Significantly different (P≤0.01) from 5.0 mg/kg acrolein (approximate equimolar dose comparison) by unpaired t-test
Significantly different (P≤0.01) from 5.0 mg/kg acrolein (MTD) by unpaired t-test
Data are presented as µg/mL of urine (mean ± standard deviation)
Below the limit of detection (1.30 µg/mL)
No data available due to 100% mortality
n=9
n=8
n=2
n=1